Serum SALL4 as a predictive biomarker for the prognosis of patients with hepatocellular carcinoma who underwent nonsurgical treatment

To investigate the role of serum spalt like transcription factor 4 (SALL4) in the hepatocellular carcinoma (HCC) patients with nonsurgical treatment. Serum samples were collected from 101 patients with HCC without surgical treatment, then the SALL4 was detected by enzyme linked immunosorbent assay....

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Zhixian, Wu, Huifeng, Jiang, Simin, Liu, Xingli, Luo, Meihua, Yuan, Yawei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9622602/
https://www.ncbi.nlm.nih.gov/pubmed/36316931
http://dx.doi.org/10.1097/MD.0000000000031200

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9622602/
https://www.ncbi.nlm.nih.gov/pubmed/36316931
http://dx.doi.org/10.1097/MD.0000000000031200

Ejemplares similares